North Carolina

Go Back to Map ←

North Carolina’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.

Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.

Total Number of Facilities in North Carolina 33
Jobs Directly Supported by the Industry in North Carolina 92223
Annual Average Wage
$111993
Total Clinical Trials
1196
Dollar Amount Invested in Clinical Trials
$648.6 Million
Clinical Trial Participants
42279
Total Clinical Trial Economic Impact
$1.8 Billion

View Facilities By District

District Total Facilities in District View Facilities in District
GA07 1

Evecxia Therapeutics

NC02 6

Aer Therapeutics, Inc.

Cypress Biopharma

FUJIFILM Diosynth Biotechnologies

Inhalon Biopharma, Inc

PharmaDirections, Inc.

SiNON Nano Sciences

NC04 20

501 Ventures

Avicenna Biosciences, Inc.

Bantam Pharmaceutical

Bayer CropScience, Inc.

Caeregen Therapeutics, LLC

ChemoGenics Biopharma, LLC

Citranvi Biosciences LLC

Dignify Therapeutics, LLC

Doron Therapeutics, Inc.

Kowa Research Institute, Inc.

Lamassu Pharma, LLC

Mycovia Pharmaceuticals, Inc.

NeuroGT, Inc.

North Carolina Biotechnology Center

North Carolina Life Sciences Organization (NCLifeSci)

Pappas Capital, LLC

Praetego, Inc.

Ribogenics, Inc.

Tellus Therapeutics

Vestaron Corporation

NC05 1

Plakous Therapeutics

NC07 2

Alcami Corporation

Cygnus Technologies, Inc

NC12 1

BioCytics, Inc.

NC13 1

GeneVentiv Therapeutics, Inc.

NC14 1

Milestone Pharmaceuticals Inc.